These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27746013)

  • 1. Cytokine-induced killer cell infusion combined with conventional treatments produced better prognosis for hepatocellular carcinoma patients with barcelona clinic liver cancer B or earlier stage: A systematic review and meta-analysis.
    Li YC; Zhao L; Wu JP; Qu CX; Song QK; Wang RB
    Cytotherapy; 2016 Dec; 18(12):1525-1531. PubMed ID: 27746013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis.
    Cao J; Kong FH; Liu X; Wang XB
    World J Gastroenterol; 2019 Jul; 25(27):3649-3663. PubMed ID: 31367163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review.
    Cai XR; Li X; Lin JX; Wang TT; Dong M; Chen ZH; Jia CC; Hong YF; Lin Q; Wu XY
    Oncotarget; 2017 May; 8(19):31318-31328. PubMed ID: 28412743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
    Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
    Gastroenterology; 2015 Jun; 148(7):1383-91.e6. PubMed ID: 25747273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data.
    Yoon JS; Song BG; Lee JH; Lee HY; Kim SW; Chang Y; Lee YB; Cho EJ; Yu SJ; Sinn DH; Kim YJ; Lee JH; Yoon JH
    BMC Cancer; 2019 May; 19(1):523. PubMed ID: 31151419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dendritic cell-based immunotherapy on hepatocellular carcinoma: A systematic review and meta-analysis.
    Chen C; Ma YH; Zhang YT; Zhang F; Zhou N; Wang X; Liu T; Li YM
    Cytotherapy; 2018 Aug; 20(8):975-989. PubMed ID: 30072299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients.
    Huang ZM; Li W; Li S; Gao F; Zhou QM; Wu FM; He N; Pan CC; Xia JC; Wu PH; Zhao M
    J Immunother; 2013 Jun; 36(5):287-93. PubMed ID: 23719239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis.
    Yu R; Yang B; Chi X; Cai L; Liu C; Yang L; Wang X; He P; Lu X
    Drug Des Devel Ther; 2017; 11():851-864. PubMed ID: 28360510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis.
    He G; Zheng C; Huo H; Zhang H; Zhu Z; Li J; Zhang H
    Int Immunopharmacol; 2016 Nov; 40():436-442. PubMed ID: 27716591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up.
    Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
    Cancer Immunol Immunother; 2019 Jan; 68(1):23-32. PubMed ID: 30232520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
    Pan K; Li YQ; Wang W; Xu L; Zhang YJ; Zheng HX; Zhao JJ; Qiu HJ; Weng DS; Li JJ; Wang QJ; Huang LX; He J; Chen SP; Ke ML; Wu PH; Chen MS; Li SP; Xia JC; Zeng YX
    Ann Surg Oncol; 2013 Dec; 20(13):4305-11. PubMed ID: 23892527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
    Pan CC; Huang ZL; Li W; Zhao M; Zhou QM; Xia JC; Wu PH
    Chin J Cancer; 2010 Jun; 29(6):596-602. PubMed ID: 20507732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocellular carcinoma.
    Yu X; Zhao H; Liu L; Cao S; Ren B; Zhang N; An X; Yu J; Li H; Ren X
    J Clin Immunol; 2014 Feb; 34(2):194-203. PubMed ID: 24337625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal perfusion of cytokine-induced killer cells with local hyperthermia for advanced hepatocellular carcinoma.
    Wang XP; Xu M; Gao HF; Zhao JF; Xu KC
    World J Gastroenterol; 2013 May; 19(19):2956-62. PubMed ID: 23704829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of cytokine-induced killer cell with valproate inhibits growth of hepatocellular carcinoma cell in a mouse model.
    Lee DH; Nam JY; Chang Y; Cho H; Kang SH; Cho YY; Cho E; Lee JH; Yu SJ; Kim YJ; Yoon JH
    Cancer Biol Ther; 2017 Jan; 18(1):67-75. PubMed ID: 28055304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of DC-CIK combined with sorafenib in the treatment of advanced hepatocellular carcinoma.
    Zhou Z; Qin H; Weng L; Ni Y
    J BUON; 2019; 24(2):615-621. PubMed ID: 31128014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma.
    Hui D; Qiang L; Jian W; Ti Z; Da-Lu K
    Dig Liver Dis; 2009 Jan; 41(1):36-41. PubMed ID: 18818130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
    Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
    Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas.
    Weng DS; Zhou J; Zhou QM; Zhao M; Wang QJ; Huang LX; Li YQ; Chen SP; Wu PH; Xia JC
    J Immunother; 2008 Jan; 31(1):63-71. PubMed ID: 18157013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of adoptive immunotherapy in postoperative hepatocellular carcinoma.
    Zhao H; Zheng M; Wang K; Wang L; He H; Wang M; Shi Y; Huang S; Ji F; Li X; Zhu H; Wang L; Zhang X; Shi X; Zhao S; Fu B; Wu T
    J Cancer Res Ther; 2018; 14(4):807-814. PubMed ID: 29970657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.